Stock & Company Details
Dianthus Therapeutics Inc $DNTH
Price:
N/A
N/A
55M
$4.6B
52 Week High:
N/A
10 Day Average Volume:
N/A
-19.86
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DNTH technical indicators
Latest Dianthus Therapeutics Inc (DNTH) indicator readings as of 2026-10-09.
DNTH's 14-day RSI is 23.0, in oversold territory. At $82.37 it is trading 0.2% above its 200-day moving average of $82.21, and below its 50-day average of $102.62. Price sits near the lower Bollinger Band ($77.46 to $106.85). ADX reads 40.3, indicating a trending market.
Overview
magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.
Finance Bot
Ask your questions
Start by typing a question below.
